Clinical Report: Evaluation of Treatment Response in Locally Advanced RCC
Overview
This study evaluates the pathological and radiographic responses in patients with locally advanced renal cell carcinoma (RCC) following systemic therapy. The findings suggest that neoadjuvant treatment can lead to significant tumor downstaging, enhancing surgical feasibility.
Background
Renal cell carcinoma is a prevalent cancer with rising incidence rates, yet advancements in treatment have contributed to declining mortality rates. Neoadjuvant therapies, including checkpoint inhibitors and tyrosine-kinase inhibitors, are being explored to improve surgical outcomes in locally advanced RCC. Understanding treatment responses is crucial for optimizing patient management and surgical interventions.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Neoadjuvant therapy with CPI and TKI resulted in a tumor size reduction of 13–20%.
Median residual viable tumor cells post-treatment were approximately 50%.
Prior systemic therapy led to downstaging in T-stage in nearly half of the patients.
Reduction of venous tumor thrombus was observed in trials evaluating TKI monotherapy and TKI plus CPI combination therapy.
Patients not initially planned for surgery were referred for surgical intervention due to objective responses to therapy.
Clinical Implications
The results indicate that neoadjuvant systemic therapy can significantly reduce tumor size and improve surgical outcomes in patients with locally advanced RCC. Clinicians should consider these treatment strategies to enhance surgical feasibility and patient prognosis.
Conclusion
The study underscores the potential of neoadjuvant therapies in improving surgical outcomes for patients with locally advanced RCC, warranting further investigation into optimal treatment protocols.
by Konstantin E. Seifert, Hendrik Dinkel, Linda Huberth, Dorothee Tiedje, Jan Gröticke, Laura-Maria Krabbe, Frederike Tepel, Kambiz Rahbar, Christof Bernemann, Andres J. Schrader, Martin Bögemann, Martin Janssen, Katrin Schlack, Barbara Heitplatz
